View web version.
 
 
We noticed it’s been a while since you last opened an email from us! We gathered some of our more recent and popular lung cancer content that your peers have viewed. We hope this content is beneficial and helps improve the treatment options you provide your patients.
 
 
Rapid Readouts
Patient-Reported Outcomes from the Phase 3 ADAURA Trial of Adjuvant Osimertinib in EGFRm NSCLC
Institutional Perspectives in Cancer
Lung Cancer: April 14 6:30-8:30 pm
Podcast
Levy Lauds Biomarker-Driver Data in Lung Cancer 
 
We want to ensure that you continue to receive content that’s interesting and relevant to you. Please take a moment to choose which types of communications you’d like to receive in our email preference center.  
 
Update email preferences